Brief: Knight Therapeutics Reports Fourth Quarter And Year End 2020 Results
25/03/2021 11:41
March 25 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR END
2020
RESULTS
* KNIGHT THERAPEUTICS INC - QTRLY REVENUE $55.2 MILLION
VERSUS
$37.3 MILLION
* KNIGHT THERAPEUTICS INC - QTRLY BASIC EARNINGS PER SHARE
$0.063
Source text for Eikon: ID:nGNX7dJPjR
Further company coverage: GUD.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil